Variagenics Signs Three New Licenses For Cardiovascular Disease Gene | GenomeWeb

NEW YORK, Jan. 16-Variagenics said today that it has licensed its patents on the methylenetetrahydrofolate reductase gene to GeneOhm Sciences, Sciona, and Tm Bioscience. Variations in the MTHFR gene may be related to thromboembolic disease risk.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.